Sangamo Therapeutics, Inc.SGMONASDAQ
LOADING
|||
Net Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-97.94M
↑ 17% above average
Average (9y)
$-117.78M
Historical baseline
Range
High:$-40.70M
Low:$-257.83M
CAGR
+10.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-97.94M | +62.0% |
| 2023 | $-257.83M | -34.1% |
| 2022 | $-192.28M | -7.8% |
| 2021 | $-178.29M | -47.3% |
| 2020 | $-121.00M | -27.1% |
| 2019 | $-95.19M | -39.3% |
| 2018 | $-68.33M | -25.2% |
| 2017 | $-54.57M | +23.8% |
| 2016 | $-71.66M | -76.1% |
| 2015 | $-40.70M | - |